| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.0026 | 1 |